miR-107 and miR-126 and Risk of Breast Cancer: A Case–Control Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-107 and miR-126 and Risk of Breast Cancer: A Case–Control Study

Published:2024-04-01 Issue:4 Volume:28 Page:165-168
ISSN:1945-0265
Container-title:Genetic Testing and Molecular Biomarkers
language:en
Short-container-title:Genetic Testing and Molecular Biomarkers

Author:

Gupta Priyanka¹^ORCID,Sambyal Vasudha¹,Bali Jagmohan Singh¹,Guleria Kamlesh¹^ORCID,Uppal Manjit Singh²,Sudan Meena³

Affiliation:

1. Department of Human Genetics, Human Cytogenetics Laboratory, Guru Nanak Dev University, Amritsar, Punjab, India.

2. Department of Surgery, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.

3. Department of Radiotherapy, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, Punjab, India.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/gtmb.2023.0606

Reference14 articles.

1. MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating brain-derived neurotrophic factor

2. MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer

3. Deregulation of miR-126-3p in basal-like breast cancers stroma and its clinical significance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP